GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HighTide Therapeutics Inc (HKSE:02511) » Definitions » Market Cap

HighTide Therapeutics (HKSE:02511) Market Cap : HK$3,165.84 Mil (As of May. 20, 2024)


View and export this data going back to 2023. Start your Free Trial

What is HighTide Therapeutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). HighTide Therapeutics's share price for the quarter that ended in Dec. 2023 was HK$12.96. HighTide Therapeutics's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 514.77 Mil. Therefore, HighTide Therapeutics's market cap for the quarter that ended in Dec. 2023 was HK$6,671.43 Mil.

HighTide Therapeutics's quarterly market cap stayed the same from Dec. 2022 (HK$0.00 Mil) to Jun. 2023 (HK$0.00 Mil) but then increased from Jun. 2023 (HK$0.00 Mil) to Dec. 2023 (HK$6,671.43 Mil).

HighTide Therapeutics's annual market cap stayed the same from Dec. 2021 (HK$0.00 Mil) to Dec. 2022 (HK$0.00 Mil) but then increased from Dec. 2022 (HK$0.00 Mil) to Dec. 2023 (HK$6,671.43 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. HighTide Therapeutics's Enterprise Value for Today is HK$2,421.91 Mil.


HighTide Therapeutics Market Cap Historical Data

The historical data trend for HighTide Therapeutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HighTide Therapeutics Market Cap Chart

HighTide Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Market Cap
- - 6,671.43

HighTide Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap - - - - 6,671.43

Competitive Comparison of HighTide Therapeutics's Market Cap

For the Biotechnology subindustry, HighTide Therapeutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HighTide Therapeutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HighTide Therapeutics's Market Cap distribution charts can be found below:

* The bar in red indicates where HighTide Therapeutics's Market Cap falls into.



HighTide Therapeutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

HighTide Therapeutics's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=HK$12.96*514.771
=HK$6,671.43

HighTide Therapeutics's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=HK$12.96*514.771
=HK$6,671.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HighTide Therapeutics  (HKSE:02511) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


HighTide Therapeutics Market Cap Related Terms

Thank you for viewing the detailed overview of HighTide Therapeutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


HighTide Therapeutics (HKSE:02511) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ganli Second Road, 18B-102, Zhonghaixin Innovation Industry City, Jihua Neighborhood, Longgang District, Guangdong, Shenzhen, CHN, 518112
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The company has developed a product pipeline of five product candidates in-house, covering nine indications in metabolic and digestive diseases among which, five are at clinical-stage. The Core Product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases.

HighTide Therapeutics (HKSE:02511) Headlines

No Headlines